Clinical Trial Update: Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy

View source ↗

Summary

A completed pharmacogenomic study evaluating chemotherapy response in patients with lung cancer, colorectal cancer, and head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Lung Cancer, Colorectal Cancer | Status: COMPLETED